2015 ACC/AHA Focused Update of Secondary Prevention Lipid Performance Measures: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures

Circulation: Cardiovascular Quality and Outcomes

Volumn 9, Issue 1, 2016, Pages 68-95

  Drozda, Joseph P ^a   Ferguson, T Bruce ^a   Jneid, Hani ^a   Krumholz, Harlan M ^a   Nallamothu, Brahmajee K ^a   Olin, Jeffrey W ^a   Ting, Henry H ^a   Heidenreich, Paul A ^a   Albert, Nancy M ^a   Chan, Paul S ^a   Curtis, Lesley H ^a   Fonarow, Gregg C ^a   Ho, P Michael ^a   O'Brien, Sean ^a   Russo, Andrea M ^a   Thomas, Randal J ^a   Varosy, Paul D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL DECISION MAKING; CLINICAL PRACTICE; CLINICAL STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; HEALTH CARE QUALITY; HEALTH LITERACY; HUMAN; INFORMATION SYSTEM; LIPID ANALYSIS; MEDICATION COMPLIANCE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PATIENT PARTICIPATION; PERCUTANEOUS CORONARY INTERVENTION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POLYPHARMACY; PRACTICE GUIDELINE; PRESCRIPTION; PRIMARY PREVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SECONDARY PREVENTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TOTAL QUALITY MANAGEMENT; TRANSIENT ISCHEMIC ATTACK; UNSTABLE ANGINA PECTORIS; ADVISORY COMMITTEE; CARDIOLOGY; CARDIOVASCULAR DISEASES; HYPERLIPIDEMIAS; MEDICAL SOCIETY; PROCEDURES; STANDARDS; UNITED STATES;

ADVISORY COMMITTEES; AMERICAN HEART ASSOCIATION; CARDIOLOGY; CARDIOVASCULAR DISEASES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; MEDICATION ADHERENCE; PRACTICE GUIDELINES AS TOPIC; SECONDARY PREVENTION; UNITED STATES;

EID: 84955274929     PISSN: 19417713     EISSN: 19417705     Source Type: Journal    
DOI: 10.1161/HCQ.0000000000000014     Document Type: Review

References (53)

1. Bonow RO, Masoudi FA, Rumsfeld JS, ACC/AHA classification of care metrics: performance measures and quality metrics: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. Circulation 2008 118 2662 6
2. Spertus JA, Eagle KA, Krumholz HM, American College of Cardiology and American Heart Association methodology for the selection and creation of performance measures for quantifying the quality of cardiovascular care. Circulation 2005 111 1703 12
3. Spertus JA, Bonow RO, Chan P, ACCF/AHA new insights into the methodology of performance measurement. Circulation 2010 122 2091 106
4. Anderson JL, Heidenreich PA, Barnett PG, ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines. Circulation 2014 129 2329 45
5. Stone NJ, Robinson JG, Lichtenstein AH, 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014 129 suppl 2 S1 45
6. Olin JW, Allie DE, Belkin M, ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 performance measures for adults with peripheral artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures, the American College of Radiology, the Society for Cardiac Angiography and Interventions, the Society for Interventional Radiology, the Society for Vascular Medicine, the Society for Vascular Nursing, and the Society for Vascular Surgery (Writing Committee to Develop Clinical Performance Measures for Peripheral Artery Disease) Developed in collaboration with the American Association of Cardiovascular and Pulmonary Rehabilitation; the American Diabetes Association; the Society for Atherosclerosis Imaging and Prevention; the Society for Cardiovascular Magnetic Resonance; the Society of Cardiovascular Computed Tomography; and the PAD Coalition. Circulation 2010 122 2583 618
7. Krumholz HM, Anderson JL, Bachelder BL, ACC/AHA 2008 performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for ST-Elevation and Non-ST-Elevation Myocardial Infarction) Developed in collaboration with the American Academy of Family Physicians and American College of Emergency Physicians. Circulation 2008 118 2598 648
8. Nallamothu BK, Tommaso CL, Anderson HV, ACC/AHA/SCAI/AMA convened PCPI/NCQA 2013 performance measures for adults undergoing percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures, the Society for Cardiovascular Angiography and Interventions, the American Medical Association Convened Physician Consortium for Performance Improvement, and the National Committee for Quality Assurance. Circulation 2014 129 926 49
9. Drozda J, Messer JV, Spertus J, ACCF/AHA/AMA PCPI 2011 performance measures for adults with coronary artery disease and hypertension: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association Physician Consortium for Performance Improvement. Circulation 2011 124 248 70
10. Normand SL, McNeil BJ, Peterson LE, Eliciting expert opinion using the Delphi technique: identifying performance indicators for cardiovascular disease. Int J Qual Health Care 1998 10 247 60
11. Kumar A, Fonarow GC, Eagle KA, Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry. Crit Pathw Cardiol 2009 8 104 11
12. Rabus SA, Izzettin FV, Sancar M, Five-year follow-up of drug utilization for secondary prevention in coronary artery disease. Pharm World Sci 2008 30 753 8
13. Maddox TM, Chan PS, Spertus JA, Variations in coronary artery disease secondary prevention prescriptions among outpatient cardiology practices: insights from the NCDR (National Cardiovascular Data Registry). J Am Coll Cardiol 2014 63 539 46
14. Arnold SV, Spertus JA, Tang F, Statin use in outpatients with obstructive coronary artery disease. Circulation 2011 124 2405 10
15. Smolderen KG, Spertus JA, Tang F, Treatment differences by health insurance among outpatients with coronary artery disease: insights from the National Cardiovascular Data Registry. J Am Coll Cardiol 2013 61 1069 75
16. Shah ND, Dunlay SM, Ting HH, Long-Term medication adherence after myocardial infarction: experience of a community. Am J Med 2009 122 961 13
17. Borden WB, Redberg RF, Mushlin AI, Patterns and intensity of medical therapy in patients undergoing percutaneous coronary intervention. JAMA 2011 305 1882 9
18. Arnold SV, Kosiborod M, Tang F, Patterns of statin initiation, intensification, and maximization among patients hospitalized with an acute myocardial infarction. Circulation 2014 129 1303 9
19. Javed U, Deedwania PC, Bhatt DL, Use of intensive lipid-lowering therapy in patients hospitalized with acute coronary syndrome: an analysis of 65,396 hospitalizations from 344 hospita participating in Get With The Guidelines (GWTG). Am Heart J 2011 161 418 24
20. Roger VL., The quality of quality: is it time for new tools? Circulation 2014 129 1270 2
21. Libby P, Ridker PM, Hansson GK., Progress and challenges in translating the biology of atherosclerosis. Nature 2011 473 317 25
22. Kashani A, Phillips CO, Foody JM, Risks associated with statin therapy: a systematic overview of randomized clinical trials. Circulation 2006 114 2788 97
23. Baigent C, Blackwell L, Emberson J, Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-Analysis of data from 170,000 participants in 26 randomised trials. Lancet 2010 376 1670 81
24. Ioannidis JP, Lau J., Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas. JAMA 2001 285 437 43
25. Ethgen M, Boutron I, Steg PG, Reporting of harm in randomized controlled trials evaluating stents for percutaneous coronary intervention. Trials 2009 10 29
26. Ioannidis JP, Evans SJ, Gotzsche PC, Better reporting of harms in randomized trials: an extension of the CONSORT statement. Ann Intern Med 2004 141 781 8
27. Nallamothu BK, Hayward RA, Bates ER., Beyond the randomized clinical trial: the role of effectiveness studies in evaluating cardiovascular therapies. Circulation 2008 118 1294 303
28. Hayward RA, Hofer TP, Vijan S., Narrative review: lack of evidence for recommended low-density lipoprotein treatment targets: a solvable problem. Ann Intern Med 2006 145 520 30
29. Krumholz HM, Hayward RA., Shifting views on lipid lowering therapy. BMJ 2010 341 c3531
30. Hayward RA, Krumholz HM., Three reasons to abandon low-density lipoprotein targets: an open letter to the Adult Treatment Panel IV of the National Institutes of Health. Circ Cardiovasc Qual Outcomes 2012 5 2 5
31. Tavazzi L, Maggioni AP, Marchioli R, Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 2008 372 1231 9
32. Kjekshus J, Apetrei E, Barrios V, Rosuvastatin in older patients with systolic heart failure. N Engl J Med 2007 357 2248 61
33. Fellstrom BC, Jardine AG, Schmieder RE, Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med 2009 360 1395 407
34. Elwyn G, Dehlendorf C, Epstein RM, Shared decision making and motivational interviewing: achieving patient-centered care across the spectrum of health care problems. Ann Fam Med 2014 12 270 5
35. Jackevicius CA, Mamdani M, Tu JV., Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA 2002 288 462 7
36. Ting HH, Brito JP, Montori VM., Shared decision making: science and action. Circ Cardiovasc Qual Outcomes 2014 7 323 7
37. Weymiller AJ, Montori VM, Jones LA, Helping patients with type 2 diabetes mellitus make treatment decisions: statin choice randomized trial. Arch Intern Med 2007 167 1076 82
38. Krumholz HM., The new cholesterol and blood pressure guidelines: perspective on the path forward. JAMA 2014 311 1403 5
39. Montori VM, Brito JP, Ting HH., Patient-centered and practical application of new high cholesterol guidelines to prevent cardiovascular disease. JAMA 2014 311 465 6
40. Coylewright M, Branda M, Inselman JW, Impact of sociodemographic patient characteristics on the efficacy of decision aids: a patient-level meta-Analysis of 7 randomized trials. Circ Cardiovasc Qual Outcomes 2014 7 360 7
41. Subherwal S, Patel MR, Kober L, Missed opportunities: despite improvement in use of car-dioprotective medications among patients with lower-extremity peripheral artery disease, underuse remains. Circulation 2012 126 1345 54
42. Haynes RB, Ackloo E, Sahota N, Interventions for enhancing medication adherence. Cochrane Database Syst Rev 2008 CD000011
43. Iuga AO, McGuire MJ., Adherence and health care costs. Risk Manag Healthc Policy 2014 7 35 44
44. Peterson ED, Ho PM, Barton M, ACC/AHA/AACVPR/AAFP/ANA concepts for clinician patient shared accountability in performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. Circulation 2014 130 1984 94
45. Mukhtar O, Weinman J, Jackson SH., Intentional non-Adherence to medications by older adults. Drugs Aging 2014 31 149 57
46. Bailey SC, Oramasionwu CU, Wolf MS., Rethinking adherence: a health literacy-informed model of medication self-management. J Health Commun 2013 18 Suppl 1 20 30
47. Nielsen-Bohlman L, Panzer AM, Kindig DA., Health Literacy: A Prescription to End Confusion 2004 Washington, DC National Academies Press
48. Zhang NJ, Terry A, McHorney CA., Impact of health literacy on medication adherence: a systematic review and meta-Analysis. Ann Pharmacother 2014 48 741 51
49. Lehmann A, Aslani P, Ahmed R, Assessing medication adherence: options to consider. Int J Clin Pharm 2014 36 55 69
50. Physician Consortium for Performance Improvement PCPI position statement: specification and categorization of measure exclusions: recommendations to PCPI work groups: Available at: http://www.ama-Assn.org/ama/pub/physician-resources/physician-consortium-performance-improvement/about-pcpi.page?. Accessed January 6, 2015
51. American College of Cardiology NCDR PINNACLE Registry. Available at: https://www.ncdr.com/WebNCDR/pinnacle/PINNACLErequestinfo. Accessed January 6, 2015
52. Office of the National Coordinator for Health Information Technology Standards and interoperability framework: Available at: Available at http://www.siframework.org/. Accessed April 17, 2014
53. Wu AW, Kharrazi H, Boulware LE, Measure once, cut twice-Adding patient-reported outcome measures to the electronic health record for comparative effectiveness research. J Clin Epidemiol 2013 66 S12 20